Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adherence to Blood Pressure Measurement Guidelines for Patients With End-stage Renal Disease on Renal Replacement Therapy (hæmodialysis or Peritoneal Dialysis)

NCT03318653 is registered in ClinicalTrials.gov with PD Dr. Grégoire Wuerzner as lead sponsor.

NCT NCT03318653
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03318653 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adherence to Blood Pressure Measurement Guidelines for Patients With End-stage Renal Disease on Renal Replacement Therapy (hæmodialysis or Peritoneal Dialysis)
Lead sponsor
PD Dr. Grégoire Wuerzner
Phase
Observational
Overall status
Completed
Start date
June 20, 2017
Completion date
March 15, 2018
Enrollment
192 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease